Mark is 52 years old, and lives with his wife and two teenage daughters.* He is a structural engineer, and enjoys spending time with his family.
Diagnosis and treatment history
Mark was diagnosed with acromegaly six years ago, after he experienced severe vision loss. Mark had surgery to reduce a tumor impinging on the optic nerve, and then started taking Sandostatin® short-acting injection. After two weeks of Sandostatin® Injection 50 mcg t.i.d., Mark switched to Sandostatin LAR® Depot 20 mg IM intragluteally at 4-week intervals.
Mark at the moment
Although his symptoms are controlled, Mark is not completely satisfied. Balancing work, family, and monthly appointments for injections is a hassle, especially if the Sandostatin LAR® Depot is not mixed properly. When that happens, Mark has to pick up a new prescription, make another appointment, and fill out extra paperwork to get reimbursed.
Mark wants to try something more convenient and Somatuline® Depot (lanreotide) Injection (lanreotide) Injection offers the ease of a pre-mixed solution in a single, pre-filled syringe.
Do any of your patients resemble Mark?
Last year Somatuline® Depot (lanreotide) Injection helped over 6000 patients with acromegaly,2 including three fictional, but typical, patients named Mark (above), Dave, and Karen (below). See if your patients are like:
* Mark is not an actual patient. His profile is based on published data from clinical studies and review articles.
